COVID-NURSE. The development, testing and evaluation of a COVID-19 fundamental nursing care protocol: a randomised controlled trial
- Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR), UK Research and Innovation (UKRI)
- Total publications:6 publications
Grant number: MR/V02776X/1
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$412,131.24Funder
Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR), UK Research and Innovation (UKRI)Principal Investigator
PendingResearch Location
United KingdomLead Research Institution
University of ExeterResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Clinical trials for disease management
Special Interest Tags
N/A
Study Subject
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Background: nursing care is a key determinant of patient experience and correlated withsafety, clinical effectiveness, care quality, treatment outcomes and reduced overall serviceuse. No evidence-based nursing protocols exist to address the unique challenges ofnursing hospitalised patients with the SARS-CoV-2 virus.Aim: to co-create and evaluate the impact on patient experience, care quality, functionalability, treatment outcomes and costs of a nursing care protocol specifically addressingthe fundamental care requirements of hospitalised patients with the SARS-CoV-2 virus notinvasively ventilated.Methods: 2-stage mixed-methods programme, following revised 2020 complexinterventions guidance, of: 1) rapid-review, survey, co-creation consensus development ofa nursing protocol; 2) rapid-cycle cluster randomised controlled trial with embeddedprocess and economic evaluations.Deliverables:1.Fundamental nursing care protocol for hospitalised patients with the SARS-CoV-2 virusnot invasively ventilated, with proven effectiveness on patient experience, care quality,functional ability and treatment outcomes within 9 months of project inception.2.Feasible, acceptable and 'implementation-optimised' protocol for widespreadimplementation, through co-creation and changes implemented during rapid cycle trialwaves.3.Adaptable protocol designed to be generalisable for environments such as care homes,patients with other conditions requiring isolation and to global health systems viaknowledge gained in a process analysis of intervention fidelity, mechanisms, contextualfactors and implementation.4.Guidelines, education materials and strategies accessible via Health Education England,the Open University's FutureLearn web platform, and experienced NHS sites acting astraining hubs for other health Trusts/care homes/global health systems.
Publicationslinked via Europe PMC
Last Updated:3 days ago
View all publications at Europe PMC